We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Research ReportsOpen Accesscc iconby icon

Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells

    Linda B. Jacobsen

    *Address correspondence to: Linda B. Jacobsen, Berit Biotech LLC, 109 Crepe Myrtle Drive, Groveland, FL, 34736, USA. email:

    E-mail Address: linda.jacobsen@beritbiotech.com

    Berit Biotech, Groveland, FL, USA

    Roche Applied Science, Indianapolis, IN, USA

    ,
    Susan A. Calvin

    Roche Applied Science, Indianapolis, IN, USA

    &
    Edward K. Lobenhofer

    Cogenics, a Division of Clinical Data, Morrisville, NC, USA

    E.K.L.'s present address is Amgen, Inc., Thousand Oaks, CA, USA.

    Search for more papers by this author

    Published Online:https://doi.org/10.2144/000113132

    Abstract

    Transfection is used to introduce a gene of interest into a cell. To interpret the downstream results, understanding which effects are the true biological responses to the gene and which, if any, are off-target effects can be difficult. In order to discriminate true biological effects from off-target effects, we transfected a breast cancer cell line, MCF7, with a vector encoding either a reporter gene or the identical vector without the reporter gene insert. Both resulted in similar numbers of differentially expressed transcripts, suggesting that very few of the responses were directly due to the introduction of the reporter gene. We postulate that many differentially expressed transcripts are the result of the introduction of foreign DNA, as the biological processes associated with these genes are primarily associated with an immune response to a viral infection. Interestingly, different transfection reagents resulted in >10-fold difference in the number of differentially expressed transcripts. This suggests the importance of testing multiple reagents and selecting the best transfection reagent along with the appropriate vector within the context of the experimental model system to ensure that the majority of the observed responses are biological effects of the gene of interest and not based on a particular transfection process used.

    Introduction

    The insertion of exogenous DNA or RNA into a cell through the process of transfection is an important, well-established tool for molecular and cellular biologists. The application of transfection as a research tool includes the production of the protein encoded by an exogenous DNA that is either transiently maintained in the nucleus or has been integrated into the genome of the host cell, resulting in the production of a stable cell line. Other uses include: (i) introduction of short interfering RNA (siRNA) or short hairpin RNA (shRNA) to examine the impact of the decreased expression of a particular gene, (ii) studying the effects of a constitutively active or dominant negative enzyme construct, and (iii) identifying the subcellular localization of a protein by using a construct encoding the gene of interest fused to the coding region for a marker such as green fluorescent protein (GFP).

    The two most common approaches for transfecting mammalian and insect cells involve either the use of chemical reagents (usually, liposome-based) or the application of an electrical current (electroporation), which is typically used for cells grown in suspension or that are difficult to transfect using chemical reagents. Unfortunately, many transfection reagents and electroporation have considerable cytotoxic effects on the cells. Furthermore, it has long been recognized that different transfection reagents cause different levels of cytotoxicity in different cell lines. These effects are often directly attributable to the transfection reagents themselves and not the nucleic acid of interest that is being introduced to the cell.

    Additionally, published literature suggests that there are a variety of negative effects resulting from cryptic or ‘poison' sequences within the plasmid vector itself (1). This raises the question of what other effects might be a direct result of the transfection event itself or other sites in the vector and not due to the presence of the exogenous RNA or DNA selected for study. Clearly, understanding these off-target effects is important to the proper interpretation of results generated using transfected cells. Initial studies have been done that indicate these changes can be identified at the level of transcription (www.roche-applied-science.com/PROD_INF/BIOCHEMI/no4_06/pdf/22.pdf).

    For these reasons, we chose the common model cell line MCF7 to identify the effects of different transfection reagents. To pinpoint potential off-target transcriptional effects, we performed microarray-based gene expression profiling assays on cells that had been transfected with four different commercially available transfection reagents at three different time points. The microarray data was used to determine genes and biological processes that were consistently modified in the presence of only the gene of interest, or as a result of exposure to a given transfection reagent. Our findings indicate that transfection-mediated transcriptional effects need to be fully appreciated by researchers within their own model systems. This information might be used to prevent the misinterpretation of results generated when studying a specific gene of interest.

    Materials and methods

    Transfection

    MCF7 (ATCC HTB-22) cells were obtained directly from ATCC (Manassas, VA, USA) and maintained under stringent standard operating procedures to prevent cross-contamination. Cells were plated 1 day before transfection at a density of 400,000 cells/well in a 2-mL volume in 6-well plates. MCF7 cells were grown in EMEM (Cat. no. 11090081; Invitrogen, Casrlsbad, CA, USA) supplemented with 10% FBS (Cat. no. SH30070.03; Hyclone Laboratories, Logan, UT, USA), glutamine (Cat. no. 25030081; Invitrogen), non-essential amino acids (Cat. no. 11140050; Invitrogen), sodium pyruvate (Cat. no. 11360070; Invitrogen), and human recombinant insulin (Cat. no. 11376497001; Roche Applied Science, Indianapolis, IN, USA). Transfections with all reagents were performed according to the manufacturer's protocols which included performing optimization experiments to determine the most ideal transfection conditions for each reagent. In instances in which several parameters were found to be optimal for a given transfection reagent (with regard to the ratio of the volume of transfection reagent and the mass of exogenous DNA), different ratios were tested in some experiments. Table 1 lists the reagents and amounts used in the experiments performed for microarray analysis. Reagents were tested in two to four separate experiments for the 48-h time point; shorter time points were tested in fewer experiments. Four to twelve independent transfections were done in each experiment for use in microarray analysis. Two different vectors were used within the context of this project. The pM1-SEAP is a vector expressing secreted alkaline phosphatase (SEAP) and was used in all four experiments. The pM1-MT is a control vector containing an identical backbone to pM1-SEAP, but without the SEAP insert, which was used in two experiments. Vectors were diluted in OPTIMEM I Reduced Serum Medium (Invitrogen) or buffer supplied with reagent. SEAP was selected for these studies as it is secreted and has minimal effects on the biological processes within a cell (http://www.roche-applied-science.com/PROD_INF/BIOCHEMI/no4_04/PDF/p09.pdf).

    Table 1. Amounts of Reagents and DNA Used in Transfection of Cells Used in Microarray Experiments

    Quantification of transfection efficiency

    At 24 and 48 h post transfection, an aliquot of the media from the transfected cells was removed, diluted (1:400) and measured for SEAP activity according to the pack insert of the chemiluminescent SEAP Reporter Gene Assay Kit (Roche Applied Science).

    RNA extraction and gene expression profiling

    At 8, 24, and 48 h post transfection, the culture media was removed from each of the wells and the entire plate was frozen at −80°C until further processing. RNA was isolated from the frozen dishes by adding RLT lysis buffer (Qiagen, Valencia, CA, USA) to each well and then processed using RNeasy Mini Spin Columns (Qiagen) following the manufacturer's recommended procedure. The quantity and purity of the extracted RNA was evaluated using a NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) and its integrity measured using an Agilent Bioanalyzer (model no. 2100; Agilent Technologies, Santa Clara, CA, USA). For microarray hybridizations, 1 µg total RNA from each sample was labeled using the GeneChip One-Cycle Target Labeling kit (Affymetrix, Inc., Santa Clara, CA, USA) following the manufacturer's protocol to prepare complementary RNA (cRNA). The amount and quality of the cRNA was assessed using a NanoDrop ND-1000 spectrophotometer and an Agilent Bioanalyzer. The cRNA was then fragmented and hybridized to the Human U133 Plus 2.0 Array for analysis of >47,000 transcripts (Affymetrix, Inc., Santa Clara, CA, USA) for 17 h, prior to washing and scanning. Data was extracted from scanned images using GeneChip Operating Software (Affymetrix, Inc.).

    Data analysis

    Gene expression data was loaded into the Rosetta Resolver Gene Expression Analysis System version 7.1.0.1.11 (Rosetta Biosoftware, Seattle, WA, USA) using the Rosetta error model for gene expression analysis (2). An error-weighted average of biological replicate samples was calculated using Rosetta Resolver and then ratio comparisons were constructed in which the transfected samples for a given transfection reagent at a specific time point was in the numerator and the untransfected control was in the denominator. To identify differentially expressed transcripts, the following criteria were employed: absolute fold-change greater than 1.3, log ratio p-value less than 0.001, and a log10 intensity greater than −0.5. Gene ontology enrichment analysis was performed using High-Throughput GoMiner (3,4).

    Results and discussion

    When transfecting cells with a particular gene of interest, several different aspects of the experiment can result in changes to transcript levels. The gene of interest, once expressed, may impact transcript abundance for other genes besides itself. These are the desired, biologically relevant changes that are the focus of the experiment. However, the backbone of the vector containing the gene of interest as well as the selected transfection reagent may also impact transcript levels. These transcript changes are not relevant to the biology of the gene of interest and may mask mechanisms underlying the action of the gene of interest and/or complicate the downstream data analysis and interpretation. For this reason, we refer to transcript changes associated with experimental conditions that are not related to the action of the gene of interest as off-target effects.

    Differential expression comparing two vectors and two reagents

    To identify potential off-target transcriptional effects, MCF7 cells were transfected with either a control vector or the same vector in which the gene for SEAP had been inserted in the multiple cloning site. This was performed using two different transfection reagents either FuGENE HD Transfection Reagent (Roche Applied Science) or Lipofectamine 2000 Transfection Reagent (Invitrogen). Gene expression profiling was performed on each well of transfected cells and untransfected cells. The results from each transfected sample were compared with the untransfected control to identify differentially expressed transcripts as shown in Figure 1 and Tables 2 and 3. A complete list of all transcripts differentially expressed with either vector is provided in Supplementary Table 1.

    Figure 1. Overlap of differentially expressed transcripts at 48 h post-transfection resulting from a comparison of each of four different samples [two different transfection reagents (FuGENE HD and Lipofectamine 2000) and two different DNA vectors (control vector and SEAP-containing) vector].

    Differentially expressed transcripts were either (A) up-regulated or (B) down-regulated as compared with untransfected control cells. Transcripts (up-regulated, n = 74; down-regulated, n = 2) found to be differentially expressed in all four transfection samples are indicated by the bolded blue font, while transcripts (up-regulated, n = 6; down-regulated, n = 1) found to be differentially expressed only in the presence of SEAP with both transfection reagents are indicated by the bolded red font. The parenthetical number after the label denotes the number of differentially expressed transcripts for that comparison at 48 h post-transfection. “Vector” denotes the control vector lacking SEAP, while “SEAP + vector” indicates the identical vector backbone containing a SEAP insert in the multiple cloning site.

    Table 2. Transcripts Differentially Expressed at 48 h in SEAP-expressing Cells
    Table 3. Top Seven Enriched Gene Ontology (GO) Categories: SEAP-containing or Control Vectors

    The overlap of these lists of transcripts was examined to identify if the transcript changes could be explained entirely by the gene of interest. Figure 1 clearly illustrates that a small number (up-regulated, n = 6, red font in Figure 1A; down-regulated, n = 1, red font in Figure 1B) were found to be differentially expressed in the presence of SEAP with both transfection reagents, which is consistent with the expectation that SEAP (commonly used as a reporter construct) has very little biological activity within the cell. The seven probes that were found to be differentially expressed only in SEAP-expressing cells after 48 h are listed in Table 2. The two probes present on the microarray that correspond to SEAP are included in this list. Three of the probes correspond to sequences that are not currently annotated to known genes, but do not have sequence similarity to SEAP (data not shown). In addition, only two genes of known function were found to be consistently regulated in the presence of SEAP: SCOTIN and NBPF3.

    Several transcripts (up-regulated, n = 74, blue font in Figure 1A; down-regulated, n = 2, blue font in Figure 1B) were found to be differentially expressed in all four transfected samples. As the only commonalities in all four samples are the vector backbone and the presence of a lipid-based transfection reagent, these changes likely reflect true off-target effects. These probes were mapped to 59 different genes. A Gene Ontology enrichment analysis was performed using GoMiner to identify the biological themes that were enriched in this group of genes. Table 3 details the top seven most significantly enriched categories.

    Interestingly, the seven categories affected (Table 3) suggest that the common biological effect across all transfections was the cellular response to the introduction of foreign DNA, similar to a viral infection or intrinsic cellular immune response. The response to viruses might be predicted as the host MCF7 cell is responding to foreign DNA. We did not determine if these responses were the result of “poison sequences” reported in plasmids over a quarter of a century ago (1), “demon sequences” (5), or plasmid methylation and CpG motifs known to induce an immune response (6–8).

    In addition to the transcripts that were differentially expressed by both reagents, there were a large number of transcripts that were changed in the presence of Lipofectamine 2000, regardless of the presence or absence of the gene of interest (up-regulated, n = 450, Figure 1A; down-regulated, n = 477, Figure 1B). This was not observed with the FuGENE HD Transfection Reagent (up-regulated, n = 0, Figure 1A; down-regulated, n = 1, Figure 1B), indicating that transfection reagents differ greatly in the extent to which they cause off-target effects.

    Differential expression at three time points comparing four reagents

    In order to more fully explore the hypothesis that transfection reagents differ in the extent to which they generate off-target effects, MCF7 cells were transfected with pM1-SEAP vector using two additional transfection reagents, Effectene (Qiagen) and Lipofectamine LTX with Plus Reagent (Invitrogen), in addition to using Lipofectamine 2000 and FuGENE HD Transfection Reagents. Samples were harvested from the transfected and corresponding untransfected control samples at three different time points: 8, 24, and 48 h post-transfection. SEAP expression was measured at the 24- and 48-h time points to demonstrate that transfections were successful and that the gene of interest had been introduced into the cells. With all reagents higher levels of SEAP expression was measured at 48 h post-transfection than at the 24-h time point as shown in Figure 2 for one experiment. (SEAP expression in untransfected cells and cells transfected with the pM1-MT (control) vector were 700–1500 relative light units).

    Figure 2. SEAP expression following transfection using different reagents at two different time points.

    MCF7 cells were transfected with SEAP using four different reagents, and total SEAP expression was determined at 24 and 48 h post-transfection. Results from one experiment are shown; similar results were found in replicate experiments.

    Next, gene expression profiling was performed on each sample and the SEAP-transfected sample was compared with the untransfected control at each time point for each transfection reagent. Table 4 details the number of transcripts identified as differentially expressed at each time point. Interestingly, the number of up-regulated transcripts significantly outnumbered the number of down-regulated transcripts in most comparisons. It is clearly evident that the number of transcripts differentially expressed increased with time post-transfection and is very dependent upon the transfection reagent selected. Significantly, the FuGENE HD Transfection Reagent consistently produced the fewest total number of differentially expressed transcripts.

    Table 4. Differentially Expressed Transcripts

    Within each time point, the overlap of each transfection reagent was identified as illustrated in Figure 3. Only a small subset of probes were found to be differentially expressed in the presence of SEAP with all four transfection reagents: two probes at 8 h (Figure 3A), 35 probes at 24 h (Figure 3B), and 135 probes (only eight of which were down-regulated) at 48 h (Figure 3C). The two transcripts differentially expressed by all four reagents at 8 h were directly related to alkaline phosphatase expression, the gene sequence that was transfected for expression, indicating how quickly the cell can transcribe the heterologous gene. A complete list of all differentially expressed transcripts at 8, 24, and 48 h is provided in Supplementary Table 2.

    Figure 3. Overlap of differentially expressed transcripts resulting from different transfection reagents at three different time points.

    Transcripts differentially expressed in cells transfected with pM1-SEAP vector, as compared with the corresponding untransfected control, at (A) 8 h, (B) 24 h, and (C) 48 h post-transfection. Transcripts found to be differentially expressed in the presence of all four transfection reagents are indicated by the bolded blue font. The parenthetical number after the label denotes the total number of differentially expressed transcripts for that reagent.

    The 135 probes (Figure 3C) differentially expressed at 48 h in cells transfected by all four reagents mapped to 80 different genes. A Gene Ontology enrichment analysis was performed on this set of genes to identify the biological themes. The seven most enriched categories following transfection at 48 h by all four reagents were identical to the categories enriched in the analysis of the effects by the vector with and without the SEAP insert as discussed earlier (Table 3). The categorical ranking was also similar; the only differences were that the top two categories exchanged positions as did the fifth and sixth categories. This suggests that these biological processes are either affected by the transfection process itself (e.g., cellular responses to membrane perturbations) or the introduction of foreign DNA into the cells. As discussed previously, different vector constructs may impact different sets of genes. While this cannot be discerned from the data (as all transfections used the same vector backbone), these findings suggest the possibility that different plasmid vectors could evoke different cellular responses. As expected, the two transcripts directly related to alkaline phosphatase expression were included among the 135 probes.

    Interestingly, a larger number of probes were found to be differentially expressed in three of the four transfection reagents (235, 8, 1, and 1, depending upon which transfection reagents are compared) as shown in Figure 3C. The greatest overlap (235 probes) was observed when examining the overlap of the Lipofectamine 2000, LTX Plus, and Effectene transfection reagents; these transcripts were not altered when FuGENE HD Transfection Reagent was used for the transfection. These 235 probes were mapped to 165 different genes to evaluate the biological response that was unique to three of the four reagents. A Gene Ontology enrichment analysis was performed using this set of genes. Table 5 details the top 10 most significantly enriched categories. Most of the processes detailed in this list are associated with translation and cellular metabolic processes in addition to antigen processing and presentation.

    Table 5. Top Ten Enriched Gene Ontology (GO) Categories: SEAP-containing Vectors

    Introduction of a gene into cells is frequently used in the field of immunology to better understand antigen processing and the molecular mechanisms underlying immune responses. Restifo et al. proposed that down-regulation of antigen processing may be one of the strategies used by tumors to escape immune surveillance (9). MCF7 cells were included among the tumor cells tested for deficiencies in antigen processing of MHC Class 1 molecules in their studies. Therefore, it was interesting to note that this pathway is affected by each of the transfection reagents that were used in our study. Table 5 shows that 3 of the 11 transcripts in this category were affected by these three reagents. We then reexamined the other eight transcripts in this pathway and found that 5 were among the 135 transcripts altered by all four reagents. Thus, among the reagents tested, FuGENE HD Transfection Reagent impacted the fewest number of transcripts implicated in the regulation of the antigen processing pathway (n = 5, all other transfection reagents resulted in the differential expression of eight transcripts). From this observation, we would predict that FuGENE HD Transfection Reagent would have the least impact on investigations in which the gene of interest is implicated in biological pathways associated with immune-related functions. As an example, Trgovcich and colleagues had difficulties studying viral evasion and modulation of host immune responses because the transfection reagents themselves were activating the same antiviral cellular response as was being studied (www.roche-applied-science.com/PROD_INF/BIOCHEMI/no3_06/pdf/20.pdf, and personal communication). They found FuGENE HD Transfection Reagent resulted in minimal induction of interferon-stimulating genes; thereby permitting a better understanding of the actual cellular response in the presence of viral gene sequences. Their finding is consistent with our observation of a significantly lower number of differentially expressed transcripts when using the FuGENE HD Transfection Reagent. Further studies could be done to determine if this is a specific result of the introduction of particular portions of the vector constructs used in the studies, or a more general response due to the delivery of foreign DNA.

    As previously discussed, all four reagents resulted in differential expression of the same 135 transcripts, but as shown in Figure 3C, each reagent also had a unique combination of additional transcripts that were differentially expressed. Some transcripts were differentially expressed only in cells transfected by a particular reagent. Many other transcripts were found to be differentially expressed in two out of the four or three out of the four different reagents. Thus, it is clear that the gene expression observed with each tested transfection reagent is likely due to off-target effects associated with these reagents rather than introduction and subsequent expression of a specific gene.

    Conclusion

    Cellular transfection is a complex process that can produce both direct (intended) and indirect (unintended) results. Foreign DNA is brought into a cell and then transported to the nucleus where new mRNA is made and eventually translated into protein. The process of foreign DNA entering into the cell has the potential to cause biological responses that are unrelated to the gene encoded by the DNA.

    To begin to unravel this complicated process, we used gene expression profiling to determine which genes and biologic categories were affected following transfection by different reagents. A control vector that did not contain the gene selected for expression was used to begin identification of transcripts differentially expressed that might be attributed to sequences within the vector backbone. The resulting data suggests that (i) many of the 135 transcripts that were found to be differentially expressed by all four transfection reagents are likely associated with the introduction of foreign DNA into cells, (ii) many off-target effects are specific to the transfection reagent itself, and (iii) only a limited number of transcripts result from the introduction and subsequent expression of a specific gene. These results suggest that transfection-mediated transcriptional effects need to be fully appreciated by researchers within their own model systems in order to prevent the misinterpretation of results generated when studying a specific gene of interest.

    Acknowledgments

    The authors wish to thank Jennifer Biesterfeldt for raising questions about early events following transfection that ultimately led to the generation of these data; Jay Wang for technical assistance; and the Gene Expression Profiling Group of Cogenics, a Division of Clinical Data, for performing the RNA isolations and the microarray work. We also thank Joanne Trgovcich and Simone Pitz for valuable discussions.

    L.B.J. and S.A.C. were employed by Roche Applied Science while performing the experiments. E.K.L. declares no competing interests.

    References

    • 1. Lusky, M. and M. Botchan. 1981. Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature 293:79–81.
    • 2. Weng, L., H. Dai, Y. Zhan, Y. He, S.B. Stepaniants, and D.E. Bassett. 2006. Rosetta error model for gene expression analysis. Bioinformatics 22:1111–1121.
    • 3. Zeeberg, B.R., W. Feng, G. Wang, M.D. Wang, A.T. Fojo, M. Sunshine, S. Narasimhan, D.W. Kane, et al.. 2003. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4:R28.
    • 4. Zeeberg, B.R., H. Qin, S. Narasimhan, M. Sunshine, H. Cao, D.W. Kane, M. Reimers, R.M. Stephens, et al.. 2005. High-Throughput GoMiner, an “industrial-strength” integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of common variable immune deficiency (CVID). BMC Bioinformatics 6:168.
    • 5. Kushner, P.J., J.D. Baxter, K.G. Duncan, G.N. Lopez, F. Schaufele, R.M. Uht, P. Webb, and B.L. West. 1994. Eukaryotic regulatory elements lurking in plasmid DNA: the activator protein-1 site in pUC. Mol. Endocrinol. 8:405–407.
    • 6. Coban, C., K.J. Ishii, M. Gursel, D.M. Klinman, and N. Kumar. 2005. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J. Leukoc. Biol. 78:647–655.
    • 7. Gursel, M., D. Verthelyi, I. Gursel, K.J. Ishii, and D.M. Klinman. 2002. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71:813–820.
    • 8. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M.D. Nguyen, G.J. Silverman, M. Lotz, et al.. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352–354.
    • 9. Restifo, N.P., F. Esquivel, Y. Kawakami, J.W. Yewdell, J.J. Mule, S.A. Rosenberg, and J.R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265–272.